Elucidate a low volume high value product giving the example of insulin. Mention the role of Indian…

Question

Elucidate a low volume high value product giving the example of insulin. Mention the role of Indian companies for its production.

Ghissu Editorial · Accepted Answer

Insulin is a low volume high value product because it needs advanced recombinant biotechnology and strict quality control, yet commands high value as a life-saving diabetes drug. Indian firms such as Biocon pioneered affordable biosimilar insulin, aided by the ₹15,000 crore PLI Scheme and Andhra Pradesh's Bulk Drug Park.

**Introduction**

Low volume high value products such as insulin are vital due to their complexity and strategic importance. Insulin’s domestic production addresses rising diabetes prevalence and reduces import reliance, notably in ==Andhra Pradesh⟦1⟧==.

**Institutional Support and Capacity**

1. **PLI Scheme for Pharmaceuticals⟦2⟧**: With a ₹15,000 crore outlay, the PLI Scheme promotes domestic manufacturing of insulin and critical biopharmaceuticals, enhancing global competitiveness.  
2. **Bulk Drug Parks in Andhra Pradesh**: ==Andhra Pradesh== benefits from Bulk Drug Parks receiving up to ₹1,000 crore, providing infrastructure crucial for high-value insulin production.  
3. **Regulatory Reforms**: The new Drugs, Medical Devices and Cosmetics Bill aims to streamline biologics regulation, improving quality and global acceptance of Indian insulin.  
4. **Public-Private Partnerships**: Indian firms collaborate with research institutions and global pharma, leveraging biotechnology expertise as seen in vaccine production.

**Challenges and Market Outcomes**

1. **Import Dependence on APIs**: Indian insulin makers rely heavily on imported APIs, especially from China, affecting costs and supply resilience.  
2. **R&D Investment Gaps**: Indian pharma’s focus on generics limits innovation in insulin and biologics development.  
3. **Access and Affordability**: High complexity limits insulin affordability; government schemes like Pradhan Mantri Bhartiya Janaushadhi Pariyojana improve access.

**Role of Indian Companies**

2. **Manufacturing Scale**: Indian companies have expanded cGMP-compliant facilities, supporting global supply.  
3. **Collaborations and Access**: Partnerships with multinationals and government schemes enhance insulin availability in ==Andhra Pradesh== and nationwide.

**Way Forward**

2. **Regulatory Harmonization and PPPs**: Expedite updated regulations and foster collaborations to scale insulin production and distribution.

**Conclusion**

Insulin’s domestic production, supported by PLI schemes and Indian biotech leadership, is crucial for India’s healthcare security and economic growth.

Model answer

ఈ ప్రశ్నను ప్రాక్టీస్ చేయండి

Ghissu